ХАЙНИ, Адриан (CH),РИЧЕЛЬ,Эрнст Теодор (DE),АЛЕКСАНДЕР, Кристиан (DE),БРАНДЕНБУРГ, Клаус (DE),УЛЬМЕР, Артур Й. (DE),МАК, Жан-Пьер (CH),ГОРЧИНСКИ, Реджинальд М. (CA),ХОЙМАНН, Дидье (CH)
申请号：
RU2015148191
公开号：
RU2015148191A
申请日:
2014.04.11
申请国别(地区):
RU
年份:
2017
代理人:
摘要：
The present invention relates to a pharmaceutical composition comprising at least one Toll-like receptor (TLR)-activating amphiphilic lipid and at least one hemoglobin-derived peptide and optionally a pharmaceutically acceptable carrier. The present invention also relates to the pharmaceutical composition according to the invention for use in preventing and/or treating tumours, preventing and/or treating infections, preventing and/or treating allergies, preventing and/or treating age-related immune imbalances, stimulating the innate and adaptive immune system and/or alleviating the adverse side effects of irradiation. Moreover, the present invention also relates to a hemoglobin-derived peptide as well as its use in treating a bacterial infection.
